Literature DB >> 22212229

Congenital hepatic fibrosis in autosomal recessive polycystic kidney disease.

Jessica Wen1.   

Abstract

Autosomal recessive polycystic kidney disease (ARPKD) is a developmental disorder that mainly affects the kidneys and the biliary tract. Affected patients often have massively enlarged cystic kidneys as well as congenital hepatic fibrosis (CHF) characterized by dilated bile ducts and associated peribiliary fibrosis. This review will examine what is known about ARPKD-associated liver disease and will highlight areas of ongoing research into its pathogenesis and potential treatment.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22212229      PMCID: PMC3252199          DOI: 10.1111/j.1752-8062.2011.00306.x

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN: 1752-8054            Impact factor:   4.689


  83 in total

Review 1.  Impact of mammalian target of rapamycin inhibition on autosomal-dominant polycystic kidney disease.

Authors:  R P Wüthrich; A D Kistler; A L Serra
Journal:  Transplant Proc       Date:  2010-11       Impact factor: 1.066

2.  Characterization of a novel polycystic kidney rat model with accompanying polycystic liver.

Authors:  M Katsuyama; T Masuyama; I Komura; T Hibino; H Takahashi
Journal:  Exp Anim       Date:  2000-01

3.  Sirolimus attenuates disease progression in an orthologous mouse model of human autosomal dominant polycystic kidney disease.

Authors:  Iram Zafar; Kameswaran Ravichandran; Franck A Belibi; R Brian Doctor; Charles L Edelstein
Journal:  Kidney Int       Date:  2010-08-04       Impact factor: 10.612

4.  Inhibition of mTOR with sirolimus does not attenuate progression of liver and kidney disease in PCK rats.

Authors:  Catharina Renken; Dagmar-Christiane Fischer; Günther Kundt; Norbert Gretz; Dieter Haffner
Journal:  Nephrol Dial Transplant       Date:  2010-07-07       Impact factor: 5.992

5.  Sirolimus and kidney growth in autosomal dominant polycystic kidney disease.

Authors:  Andreas L Serra; Diane Poster; Andreas D Kistler; Fabienne Krauer; Shagun Raina; James Young; Katharina M Rentsch; Katharina S Spanaus; Oliver Senn; Paulus Kristanto; Hans Scheffel; Dominik Weishaupt; Rudolf P Wüthrich
Journal:  N Engl J Med       Date:  2010-06-26       Impact factor: 91.245

6.  Everolimus in patients with autosomal dominant polycystic kidney disease.

Authors:  Gerd Walz; Klemens Budde; Marwan Mannaa; Jens Nürnberger; Christoph Wanner; Claudia Sommerer; Ulrich Kunzendorf; Bernhard Banas; Walter H Hörl; Nicholas Obermüller; Wolfgang Arns; Hermann Pavenstädt; Jens Gaedeke; Martin Büchert; Christoph May; Harald Gschaidmeier; Stefan Kramer; Kai-Uwe Eckardt
Journal:  N Engl J Med       Date:  2010-06-26       Impact factor: 91.245

7.  PPAR-gamma agonist ameliorates kidney and liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease.

Authors:  Daisuke Yoshihara; Hiroki Kurahashi; Miwa Morita; Masanori Kugita; Yoshiyuki Hiki; Harold M Aukema; Tamio Yamaguchi; James P Calvet; Darren P Wallace; Shizuko Nagao
Journal:  Am J Physiol Renal Physiol       Date:  2010-12-08

8.  Clinical aspects of autosomal recessive polycystic kidney disease.

Authors:  Natasha Favoretto Dias; Vivian Lanzarini; Luiz Fernando Onuchic; Vera Hermina Kalika Koch
Journal:  J Bras Nefrol       Date:  2010 Jul-Sep

9.  mTORC1/2 and rapamycin in female Han:SPRD rats with polycystic kidney disease.

Authors:  Franck Belibi; Kameswaran Ravichandran; Iram Zafar; Zhibin He; Charles L Edelstein
Journal:  Am J Physiol Renal Physiol       Date:  2010-10-13

10.  The renin-angiotensin system and hypertension in autosomal recessive polycystic kidney disease.

Authors:  Miwa Goto; Nita Hoxha; Rania Osman; Katherine Macrae Dell
Journal:  Pediatr Nephrol       Date:  2010-08-27       Impact factor: 3.714

View more
  11 in total

Review 1.  New approaches to the autosomal recessive polycystic kidney disease patient with dual kidney-liver complications.

Authors:  Grzegorz Telega; David Cronin; Ellis D Avner
Journal:  Pediatr Transplant       Date:  2013-04-17

2.  Increased YAP Activation Is Associated With Hepatic Cyst Epithelial Cell Proliferation in ARPKD/CHF.

Authors:  Lu Jiang; Lina Sun; Genea Edwards; Michael Manley; Darren P Wallace; Seth Septer; Chirag Manohar; Michele T Pritchard; Udayan Apte
Journal:  Gene Expr       Date:  2017-09-15

Review 3.  Autosomal recessive polycystic kidney disease: a hepatorenal fibrocystic disorder with pleiotropic effects.

Authors:  Erum A Hartung; Lisa M Guay-Woodford
Journal:  Pediatrics       Date:  2014-08-11       Impact factor: 7.124

4.  MALDI imaging MS reveals candidate lipid markers of polycystic kidney disease.

Authors:  Hermelindis Ruh; Theresia Salonikios; Jens Fuchser; Matthias Schwartz; Carsten Sticht; Christina Hochheim; Bernhard Wirnitzer; Norbert Gretz; Carsten Hopf
Journal:  J Lipid Res       Date:  2013-07-12       Impact factor: 5.922

5.  Evaluation of galectin-3 and intestinal fatty acid binding protein as serum biomarkers in autosomal recessive polycystic kidney disease.

Authors:  Lindsay T Fleischer; Lance Ballester; Mohini Dutt; Kathryn Howarth; Laura Poznick; Kassa Darge; Susan L Furth; Erum A Hartung
Journal:  J Nephrol       Date:  2022-08-18       Impact factor: 4.393

Review 6.  Autosomal Recessive Polycystic Kidney Disease-The Clinical Aspects and Diagnostic Challenges.

Authors:  Dorota Wicher; Łukasz Obrycki; Irena Jankowska
Journal:  J Pediatr Genet       Date:  2020-07-29

7.  Caroli's disease misdiagnosed as intraductal papillary neoplasm of the bile duct.

Authors:  Dae Hoe Gu; Min Seon Park; Chang Ho Jung; Yang Jae Yoo; Jae Young Cho; Yun Ho Lee; Yeon Seok Seo; Hyung Joon Yim; Soon Ho Um; Ho Sang Ryu
Journal:  Clin Mol Hepatol       Date:  2015-06-26

Review 8.  Evidence for a "Pathogenic Triumvirate" in Congenital Hepatic Fibrosis in Autosomal Recessive Polycystic Kidney Disease.

Authors:  Lu Jiang; Pingping Fang; James L Weemhoff; Udayan Apte; Michele T Pritchard
Journal:  Biomed Res Int       Date:  2016-11-07       Impact factor: 3.411

Review 9.  Diagnosis and Management of Hepatobiliary Complications in Autosomal Recessive Polycystic Kidney Disease.

Authors:  Andrew Wehrman; Alyssa Kriegermeier; Jessica Wen
Journal:  Front Pediatr       Date:  2017-05-29       Impact factor: 3.418

10.  Magnetic resonance microscopy of renal and biliary abnormalities in excised tissues from a mouse model of autosomal recessive polycystic kidney disease.

Authors:  Choong H Lee; Amber K O'Connor; Chaozhe Yang; Joshua M Tate; Trenton R Schoeb; Jeremy J Flint; Stephen J Blackband; Lisa M Guay-Woodford
Journal:  Physiol Rep       Date:  2015-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.